Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation
Filipa G. Pinho(University of East Anglia), Leandro Castellano(University of Sussex), Dmitri Pchejetski(University of East Anglia), João Nunes(Hospital de Câncer de Barretos), Laura Roca-Alonso(University of East Anglia), Adam E. Frampton(Hammersmith Hospital), Justin Stebbing(Anglia Ruskin University), Jonathan Waxman, Alexander de Giorgio(University of East Anglia), Victoria Harding(Hammersmith Hospital), Jimmy Jacob(University of East Anglia), Loredana Pellegrino(University of East Anglia), Heba Alshaker(University of East Anglia), Jonathan Krell(Imperial College London)
Cited by 91
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203